Health Care Providers' Testing Practices for Coccidioidomycosis and Histoplasmosis in Patients With Community-Acquired Pneumonia-United States, 2020.

Kaitlin BenedictYiman LiNoelle Angelique M MolinariBrendan R Jackson

Published in: Open forum infectious diseases (2021)

Laboratory testing is required to distinguish coccidioidomycosis and histoplasmosis from other types of community-acquired pneumonia (CAP). In this nationwide survey of 1258 health care providers, only 3.7% reported frequently testing CAP patients for coccidioidomycosis and 2.8% for histoplasmosis. These diseases are likely underdiagnosed, and increased awareness is needed.

Keyphrases

community acquired pneumonia
healthcare
end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
primary care
peritoneal dialysis
patient reported